# HeartBeam (BEAT) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/BEAT
## Company Profile
- Ticker: BEAT
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
## Stock Data
- Close: 0.572 USD
- Market cap: 48623987.46 USD
- Last updated: 2026-08-12
## Business Overview
### Ambulatory Cardiac Diagnostics
HeartBeam develops portable electrocardiogram technology intended to detect and monitor cardiac conditions outside traditional clinical settings.
### Cardiac Electrical Biomarker Platform
The company reconstructs three-dimensional cardiac electrical information from a compact consumer-oriented device and analyzes it with software and artificial intelligence.
### Commercial Care Model
HeartBeam is introducing its system through concierge medical practices and other flagship sites while integrating patient onboarding and clinical workflows.
### AI-Enabled Detection
A collaboration with Mount Sinai supports development of next-generation ECG algorithms, beginning with detection of heart attacks.
## Why The Stock Is Moving

The latest monitored company update is “HeartBeam Reports Second Quarter 2026 Results.” The corresponding closing-price reaction is not yet available.

## Future Catalysts

- Presentation of heart-attack-detection pilot data at TCT 2026 in fall 2026.

## Recent News
- 2026-08-13 20:01 EST — [HeartBeam Reports Second Quarter 2026 Results](https://biopharmsignal.com/news/BEAT/heartbeam-reports-second-quarter-2026-results-fbdf8ba8) — Source: HeartBeam
- 2026-07-30 11:00 EST — [HeartBeam to Host Second Quarter 2026 Results Conference Call on Thursday, August 13, 2026 at 4:30 p.m. Eastern Time](https://biopharmsignal.com/news/BEAT/heartbeam-to-host-second-quarter-2026-results-conference-call-on-thursday-august-4cfd76dd) — Source: HeartBeam
- 2026-07-14 11:00 EST — [HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device](https://biopharmsignal.com/news/BEAT/heartbeam-awarded-new-u-s-patent-expanding-acoustic-sensing-and-fluid-monitoring-e0c78764) — Source: HeartBeam
- 2026-06-30 11:00 EST — [HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule](https://biopharmsignal.com/news/BEAT/heartbeam-completes-enrollment-in-heart-attack-detection-pilot-study-ahead-of-sc-c3aedd75) — Source: HeartBeam
- 2026-06-24 20:05 EST — [HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition](https://biopharmsignal.com/news/BEAT/heartbeam-announces-strategic-shift-to-accelerate-global-adoption-of-its-ambulat-2e1e9ad3) — Source: HeartBeam